Siddiqui A U, Swaminathan S, Pinkerton F D, Gerst N, Wilson W K, Choi H, Schroephfer G J
Department of Biochemistry, Rice University, Houston, TX 77251-1892.
Chem Phys Lipids. 1994 Jun 24;72(1):59-75. doi: 10.1016/0009-3084(94)90017-5.
As part of a program to prepare delta 8(14)-15-ketosterols that cannot readily be metabolized to cholesterol or side-chain oxygenated species, we have prepared 3 beta-hydroxy-7 alpha-fluoro-5 alpha-cholest-8(14)-en-15-one (VII) and the 9 alpha-hydroxy (IV), 9 alpha-fluoro (VI) and 7 alpha-fluoro (VIII) derivatives of 3 beta-hydroxy-25,26,26,26,27,27,27-heptafluoro-5 alpha-cholest-8(14)-en-15-one (II). Sterol IV was prepared by oxidation of the delta 8,14 dienol ethyl ether of the 3 beta-acetate of II with m-chloroperbenzoic acid, followed by mild alkaline hydrolysis of the 3 beta-acetate derivative of IV. Treatment of IV with hydrogen fluoride-pyridine gave VI. The 7 alpha-fluoro-15-ketosterols VII and VIII were synthesized by treating the 3 beta,15-bis-trimethylsilyl delta 7,14-dienol ether derivative of the appropriate delta 8(14)-15-ketosterol with N-fluoropyridinium triflate, followed by hydrolysis of residual trimethylsilyl ethers and purification by high-performance liquid chromatography. The combined results of 1H and 13C nuclear magnetic resonance (NMR) chemical shifts, 1H-1H coupling constants, 1H-19F long-range coupling constants and molecular modeling indicated that a 7 alpha-fluoro, 9 alpha-fluoro or 9 alpha-hydroxy substituent has negligible effect on the conformation of the 15-ketosterols. 1H and 13C-NMR data are also given for delta 6,8(14)- and delta 8(14),9(11)-15-ketosterols, synthetic byproducts that could not be detected readily in samples of the fluoro-15-ketosterols by chromatographic methods. Mass spectra of VI and of previously reported 9 alpha-fluoro and 9 alpha-hydroxy-delta 8(14)-15-ketosterols showed abundant M-62 or M-60 ions that appear to correspond to loss of ketene and HF or H2O. The 9 alpha-hydroxy-F7-15-ketosterol IV, the 7 alpha-fluoro-15-ketosterol VII and the 7 alpha-fluoro-F7-15-ketosterol VIII were of equivalent potency to the parent 3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one (I) in lowering the levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in CHO-K1 cells. The 9 alpha-fluoro-F7-15-ketosterol VI showed high potency but appeared to be slightly less active than I.
作为制备不易代谢为胆固醇或侧链氧化产物的δ8(14)-15-酮甾醇计划的一部分,我们制备了3β-羟基-7α-氟-5α-胆甾-8(14)-烯-15-酮(VII)以及3β-羟基-25,26,26,26,27,27,27-七氟-5α-胆甾-8(14)-烯-15-酮(II)的9α-羟基(IV)、9α-氟(VI)和7α-氟(VIII)衍生物。甾醇IV是通过用间氯过苯甲酸氧化II的3β-乙酸酯的δ8,14-二烯醇乙醚,然后对IV的3β-乙酸酯衍生物进行温和的碱性水解来制备的。用氟化氢-吡啶处理IV得到VI。7α-氟-15-酮甾醇VII和VIII是通过用三氟甲磺酸N-氟吡啶鎓处理适当的δ8(14)-15-酮甾醇的3β,15-双三甲基硅基δ7,14-二烯醇醚衍生物,然后水解残留的三甲基硅基醚并通过高效液相色谱法纯化来合成的。1H和13C核磁共振(NMR)化学位移、1H-1H耦合常数、1H-19F远程耦合常数和分子建模的综合结果表明,7α-氟、9α-氟或9α-羟基取代基对15-酮甾醇的构象影响可忽略不计。还给出了δ6,8(14)-和δ8(14),9(11)-15-酮甾醇的1H和13C-NMR数据,这些是氟-15-酮甾醇样品中通过色谱方法不易检测到的合成副产物。VI以及先前报道的9α-氟和9α-羟基-δ8(14)-15-酮甾醇的质谱显示出丰富的M-62或M-60离子,似乎对应于乙烯酮和HF或H2O的损失。9α-羟基-F7-15-酮甾醇IV、7α-氟-15-酮甾醇VII和7α-氟-F7-15-酮甾醇VIII在降低CHO-K1细胞中3-羟基-3-甲基戊二酰辅酶A还原酶活性水平方面与母体3β-羟基-5α-胆甾-8(14)-烯-15-酮(I)具有同等效力。9α-氟-F7-15-酮甾醇VI显示出高效力,但似乎比I的活性略低。